Displaying 1–10 of 705 results
Jul 18, 2022 MST
Please join Microsoft and the Foundation Fighting Blindness and help fund valuable research to find a cure for blinding retinal diseases.
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases.
Jul 16, 2022 AKDT
All are welcome to the San Diego “Summer Fun and Games” Picnic Potluck! Bring your friends and family and spend some time with the Foundation Fighting Blindness San Diego Chapter.
Jun 30, 2022 -12
Enjoy 18 holes of golf while supporting a great cause. Includes a deluxe box lunch and welcome bag for each player with course contests, a silent auction, and more activities to come!
Jun 27, 2022
The approach bestows light sensitivity to retinal ganglion cells for people who have lost their photoreceptors
Jun 24, 2022
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts are hosted by Ben Shaberman, senior director scientific outreach, and often include conversations with guests from the research and vision communities.
Jun 21, 2022
Jason Menzo named chief executive officer • Russell Kelley, PhD, MBA, appointed managing director of the RD Fund • Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company.
Jun 20, 2022
The newly approved drug reduces the pathologic hunger associated with BBS
Jun 20, 2022
After Allison’s diagnosis with Usher syndrome type 3, her dad, Jeff Libby, wanted to do everything he could to find her a cure. As a biologist, Jeff started searching for organizations researching blinding diseases like Allison’s, and he found the Foundation Fighting Blindness.
Jun 15, 2022
Funds to support advancement of two clinical trials through proof of concept: NPI-001 for retinitis pigmentosa in Usher syndrome and NPI-002 to slow cataract progression.
Jun 13, 2022
In its seventh year, the Retinal Cell & Gene Therapy Innovation Summit featured 34 presentations from industry experts from around the world.